Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Columbia Laboratories granted U.S. patent for Crinone technology

Aug. 23, 1996

Astra's Atmos launched in Sweden

Aug. 23, 1996

Humatrope approved for new indication in U.S.

Aug. 23, 1996

Update on Biotech Holdings' Diab II

Aug. 23, 1996

Alteon initiates phase III trials of pimagedine

Aug. 23, 1996

Johnson & Johnson continues pramlintide collaboration

Aug. 23, 1996

Pramlintide shows positive safety/efficacy profile in phase II

Aug. 23, 1996

Humalog launched on U.S. market

Aug. 23, 1996

Hematopoiesis-stimulating compounds from Nycomed Pharma

Aug. 23, 1996

RIIbeta: Potential antiobesity drug target

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 8, 2025.
House passes H.R. 1, restoring R&D tax cuts
BioWorld MedTech
The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
Exercise-mimicking compound offers alternative to GLP-1 therapies
BioWorld
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
With surface mimicry, molecular glues shed hairpin need
BioWorld Science
Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...